annual CFI:
-$2.53B+$848.51M(+25.13%)Summary
- As of today (August 16, 2025), TAK annual cash flow from investing activities is -$2.53 billion, with the most recent change of +$848.51 million (+25.13%) on March 1, 2025.
- During the last 3 years, TAK annual CFI has fallen by -$708.39 million (-38.94%).
- TAK annual CFI is now -168.38% below its all-time high of $3.70 billion, reached on March 31, 2021.
Performance
TAK Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$229.52M-$97.14M(-73.38%)Summary
- As of today (August 16, 2025), TAK quarterly cash flow from investing activities is -$229.52 million, with the most recent change of -$97.14 million (-73.38%) on June 1, 2025.
- Over the past year, TAK quarterly CFI has increased by +$775.63 million (+77.17%).
- TAK quarterly CFI is now -106.64% below its all-time high of $3.46 billion, reached on September 30, 2019.
Performance
TAK quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$1.63B+$775.63M(+32.19%)Summary
- As of today (August 16, 2025), TAK TTM cash flow from investing activities is -$1.63 billion, with the most recent change of +$775.63 million (+32.19%) on June 1, 2025.
- Over the past year, TAK TTM CFI has increased by +$643.09 million (+28.24%).
- TAK TTM CFI is now -144.02% below its all-time high of $3.71 billion, reached on March 31, 2021.
Performance
TAK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TAK Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.1% | +77.2% | +28.2% |
| 3 y3 years | -38.9% | +68.6% | +11.8% |
| 5 y5 years | -198.4% | -3830.9% | -153.2% |
TAK Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.9% | +44.4% | -73.4% | +93.0% | -13.2% | +72.9% |
| 5 y | 5-year | -168.4% | +44.4% | -108.3% | +93.0% | -144.0% | +72.9% |
| alltime | all time | -168.4% | +90.2% | -106.6% | +98.4% | -144.0% | +93.7% |
TAK Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$229.52M(+73.4%) | -$1.63B(-32.2%) |
| Mar 2025 | -$2.53B(-25.1%) | -$132.38M(-81.5%) | -$2.41B(-12.9%) |
| Dec 2024 | - | -$716.72M(+29.0%) | -$2.77B(+10.2%) |
| Sep 2024 | - | -$555.58M(-44.7%) | -$2.51B(+10.2%) |
| Jun 2024 | - | -$1.01B(+105.4%) | -$2.28B(-29.2%) |
| Mar 2024 | -$3.38B(-25.7%) | -$489.35M(+6.2%) | -$3.21B(-46.6%) |
| Dec 2023 | - | -$460.58M(+42.9%) | -$6.03B(+2.5%) |
| Sep 2023 | - | -$322.20M(-83.4%) | -$5.88B(+3.0%) |
| Jun 2023 | - | -$1.94B(-41.1%) | -$5.71B(+26.9%) |
| Mar 2023 | -$4.54B(+149.7%) | -$3.30B(+952.9%) | -$4.50B(+211.5%) |
| Dec 2022 | - | -$313.42M(+106.7%) | -$1.44B(-15.5%) |
| Sep 2022 | - | -$151.60M(-79.3%) | -$1.71B(-7.8%) |
| Jun 2022 | - | -$730.96M(+195.4%) | -$1.85B(+5.0%) |
| Mar 2022 | -$1.82B(-149.2%) | -$247.48M(-57.2%) | -$1.76B(-242.8%) |
| Dec 2021 | - | -$578.38M(+95.8%) | $1.24B(-50.7%) |
| Sep 2021 | - | -$295.38M(-54.1%) | $2.51B(-18.1%) |
| Jun 2021 | - | -$643.58M(-123.4%) | $3.06B(-17.5%) |
| Mar 2021 | $3.70B(+43.9%) | $2.75B(+297.0%) | $3.71B(+186.9%) |
| Dec 2020 | - | $693.45M(+166.9%) | $1.29B(-1120.3%) |
| Sep 2020 | - | $259.79M(+4122.9%) | -$126.82M(-104.1%) |
| Jun 2020 | - | $6.15M(-98.2%) | $3.07B(+14.3%) |
| Mar 2020 | $2.57B(-110.0%) | $334.60M(-146.0%) | $2.69B(-130.2%) |
| Dec 2019 | - | -$727.37M(-121.0%) | -$8.91B(-60.4%) |
| Sep 2019 | - | $3.46B(-1013.8%) | -$22.48B(-12.9%) |
| Jun 2019 | - | -$378.52M(-96.6%) | -$25.80B(+0.9%) |
| Mar 2019 | -$25.65B(+2648.2%) | -$11.26B(-21.2%) | -$25.58B(+67.3%) |
| Dec 2018 | - | -$14.30B(<-9900.0%) | -$15.28B(+1327.4%) |
| Sep 2018 | - | $137.47M(-187.7%) | -$1.07B(-43.4%) |
| Jun 2018 | - | -$156.69M(-83.8%) | -$1.89B(+124.7%) |
| Mar 2018 | -$933.42M(-84.7%) | -$968.00M(+1058.6%) | -$842.45M(-84.9%) |
| Dec 2017 | - | -$83.55M(-87.8%) | -$5.57B(-3.0%) |
| Sep 2017 | - | -$684.96M(-176.6%) | -$5.75B(+12.3%) |
| Jun 2017 | - | $894.05M(-115.7%) | -$5.12B(-15.6%) |
| Mar 2017 | -$6.11B(+850.5%) | -$5.70B(+2101.2%) | -$6.06B(+4138.0%) |
| Dec 2016 | - | -$258.79M(+361.1%) | -$143.07M(-61.0%) |
| Sep 2016 | - | -$56.13M(+8.0%) | -$366.59M(-23.2%) |
| Jun 2016 | - | -$51.98M(-123.2%) | -$477.58M(-19.5%) |
| Mar 2016 | -$642.54M | $223.83M(-146.4%) | -$593.40M(-33.1%) |
| Dec 2015 | - | -$482.31M(+188.6%) | -$886.37M(-447.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$167.11M(-0.4%) | $255.31M(-32.6%) |
| Jun 2015 | - | -$167.81M(+142.7%) | $378.73M(-54.7%) |
| Mar 2015 | $674.71M(-142.6%) | -$69.13M(-110.5%) | $835.33M(+5.3%) |
| Dec 2014 | - | $659.36M(-1609.1%) | $793.48M(-169.2%) |
| Sep 2014 | - | -$43.69M(-115.1%) | -$1.15B(+5.5%) |
| Jun 2014 | - | $288.79M(-360.2%) | -$1.09B(-29.4%) |
| Mar 2014 | -$1.58B(+0.2%) | -$110.98M(-91.3%) | -$1.54B(+7.8%) |
| Dec 2013 | - | -$1.28B(-7897.5%) | -$1.43B(+871.7%) |
| Sep 2013 | - | $16.42M(-110.1%) | -$146.88M(-10.1%) |
| Jun 2013 | - | -$163.30M(+672.5%) | -$163.30M(-85.8%) |
| Mar 2013 | -$1.58B(-88.6%) | - | - |
| Mar 2012 | -$13.85B(+1095.4%) | - | - |
| Mar 2011 | -$1.16B(-8.4%) | -$21.14M(-94.8%) | -$1.15B(-33.4%) |
| Dec 2010 | - | -$403.51M(-18.9%) | -$1.73B(+9.8%) |
| Sep 2010 | - | -$497.71M(+116.0%) | -$1.58B(+24.5%) |
| Jun 2010 | - | -$230.38M(-61.6%) | -$1.27B(-0.0%) |
| Mar 2010 | -$1.27B(-83.4%) | -$600.29M(+141.5%) | -$1.27B(+90.1%) |
| Dec 2009 | - | -$248.53M(+32.6%) | -$666.30M(+59.5%) |
| Sep 2009 | - | -$187.37M(-18.7%) | -$417.78M(+81.3%) |
| Jun 2009 | - | -$230.41M | -$230.41M |
| Mar 2009 | -$7.63B(-956.9%) | - | - |
| Mar 2008 | $890.28M(-10.6%) | - | - |
| Mar 2007 | $995.56M(+1616.2%) | - | - |
| Mar 2006 | $58.01M(-108.6%) | - | - |
| Mar 2005 | -$672.67M(-45.4%) | - | - |
| Mar 2004 | -$1.23B(-207.2%) | - | - |
| Mar 2003 | $1.15B(+14.7%) | - | - |
| Mar 2002 | $1.00B(-290.3%) | - | - |
| Mar 2001 | -$526.74M(+13.5%) | - | - |
| Mar 2000 | -$464.03M(-65.2%) | - | - |
| Mar 1999 | -$1.33B(+124.9%) | - | - |
| Mar 1998 | -$592.35M(+48.4%) | - | - |
| Mar 1997 | -$399.05M(-14.0%) | - | - |
| Mar 1996 | -$463.90M(-21.3%) | - | - |
| Mar 1995 | -$589.34M(+56.5%) | - | - |
| Mar 1994 | -$376.52M(+66.5%) | - | - |
| Mar 1993 | -$226.11M(-1.9%) | - | - |
| Mar 1992 | -$230.46M(-10.4%) | - | - |
| Mar 1991 | -$257.11M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CFI year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CFI year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM cash flow from investing activities?
- What is the all time high TTM CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CFI year-on-year change?
What is Takeda Pharmaceutical Company Limited annual cash flow from investing activities?
The current annual CFI of TAK is -$2.53B
What is the all time high annual CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual cash flow from investing activities is $3.70B
What is Takeda Pharmaceutical Company Limited annual CFI year-on-year change?
Over the past year, TAK annual cash flow from investing activities has changed by +$848.51M (+25.13%)
What is Takeda Pharmaceutical Company Limited quarterly cash flow from investing activities?
The current quarterly CFI of TAK is -$229.52M
What is the all time high quarterly CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly cash flow from investing activities is $3.46B
What is Takeda Pharmaceutical Company Limited quarterly CFI year-on-year change?
Over the past year, TAK quarterly cash flow from investing activities has changed by +$775.63M (+77.17%)
What is Takeda Pharmaceutical Company Limited TTM cash flow from investing activities?
The current TTM CFI of TAK is -$1.63B
What is the all time high TTM CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM cash flow from investing activities is $3.71B
What is Takeda Pharmaceutical Company Limited TTM CFI year-on-year change?
Over the past year, TAK TTM cash flow from investing activities has changed by +$643.09M (+28.24%)